To test this assumption, we isolated CD326(ESA)+/CD44+/CD24−or low cells not only from the breast cancer cell lines MCF7 and MDA-MB231 but also from primary cultures of human breast tumor cells. This evidence concerns the gene EPCAM and breast carcinoma.